Press Release
PHILADELPHIA, PA, July 09, 2024 /24-7PressRelease/ — Jalil Bami attended the Leadership Council meeting alongside a distinguished group of medical professionals at the Institute of Diabetes, Obesity, and Metabolism (IDOM) at the University of Pennsylvania on Tuesday, June 11, 2024. The event, held in Philadelphia, featured influential speakers and highlighted groundbreaking research and developments in Diabetes.
The meeting included presentations from renowned experts in diabetes care and research. Michael R. Rickels, MD, MS, Mark Schutta, MD, and Mitchell Lazar, MD, PhD, are key presenters discussing updates and groundbreaking discoveries for the future of Type 1 Diabetes, emphasizing the importance of continuous research and innovation.
The meeting concluded with closing remarks from Arthur Rubenstein, MBBCh, who emphasized the critical role of dedicated professionals in advancing medical research and patient care. He stated, “It takes good people; if you don’t have good people, you can sit down and worry about nothing.”
In a significant gesture of support, Jalil Bami presented a check for $100,000 to the Diabetes Research, Education, and Clinical Care Fund at UPenn Medicine. This generous donation will enable the institution to further its extensive research efforts, educational programs, and clinical care initiatives aimed at combating Diabetes.
This donation underscores Jalil’s deep connection to the medical center and the community it serves. As a diabetic individual with a daughter who battles multiple sclerosis (MS), Jalil understands firsthand the importance of quality medical care.
“We are deeply grateful for Mr. Bami’s generous contribution,” said Hillary Schaub, Penn Medicine Development & Alumni Relations at the Institute of Diabetes, Obesity, and Metabolism. “His support will have a lasting impact on our ability to advance diabetes research and provide cutting-edge care to our patients.”
The University of Pennsylvania’s Institute of Diabetes, Obesity, and Metabolism continues to be at the forefront of diabetes research, working tirelessly to improve the lives of individuals affected by this condition. With the support of benefactors like Jalil Bami, UPenn Medicine is well-positioned to make significant strides in the fight against diabetes.
The Institute of Diabetes, Obesity, and Metabolism (IDOM) at the University of Pennsylvania is dedicated to advancing the understanding, prevention, and treatment of diabetes, obesity, and related metabolic disorders. Through cutting-edge research, comprehensive education, and innovative clinical care, IDOM aims to improve the health and well-being of individuals affected by these conditions.
—
For the original version of this press release, please visit 24-7PressRelease.com here
